Advertisement
UK markets close in 5 hours 9 minutes

  • FTSE 100

    8,093.45
    +53.07 (+0.66%)
     

  • FTSE 250

    19,723.23
    +3.86 (+0.02%)
     

  • AIM

    755.43
    +0.74 (+0.10%)
     

  • GBP/EUR

    1.1669
    +0.0025 (+0.21%)
     

  • GBP/USD

    1.2521
    +0.0058 (+0.47%)
     

  • Bitcoin GBP

    50,847.87
    -2,178.55 (-4.11%)
     

  • CMC Crypto 200

    1,360.43
    -22.15 (-1.60%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    82.76
    -0.05 (-0.06%)
     

  • GOLD FUTURES

    2,337.40
    -1.00 (-0.04%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,985.62
    -103.08 (-0.57%)
     

  • CAC 40

    8,042.97
    -48.89 (-0.60%)
     
Stock:

Trending tickers

Microsoft, Google, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Why STAAR Surgical Stock Is Triumphant Today

Alex Carchidi, The Motley Fool
·2-min read

STAAR Surgical (NASDAQ: STAA) stock was up by 16% as of 3:36 p.m. ET on Thursday after it smashed the market's expectations for its second-quarter earnings, reporting net sales of $81.1 million and $0.26 in net income per diluted share. The strong sales in China and India indicate that STAAR's ongoing push into major international vision correction markets is going swimmingly. Right now, its market share in China is estimated to be above 20%, which bodes well for its future performance there.

Continue reading